Stock Price Quote

KAYA LTD.

NSE : KAYABSE : 539276ISIN CODE : INE587G01015Industry : Hospital & Healthcare ServicesHouse : Marico
BSE339.85-11.95 (-3.4 %)
PREV CLOSE ( ) 351.80
OPEN PRICE ( ) 344.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 498
TODAY'S LOW / HIGH ( )333.60 346.15
52 WK LOW / HIGH ( )302.7 395.9
NSE339.05-13.45 (-3.82 %)
PREV CLOSE( ) 352.50
OPEN PRICE ( ) 345.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 339.05 (497)
VOLUME 19416
TODAY'S LOW / HIGH( ) 334.00 348.00
52 WK LOW / HIGH ( )303 398.55
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 2003
Management Info
Harsh Mariwala - Chairman Harsh Mariwala - Managing Director
Registered Office

Address Marks, 23/ C, Mahal Industrial Estate, Mahakali Caves Road,Near Paperbox Lane,Andheri (East),
Mumbai,
Maharashtra-400093

Phone 022 - 66195000

Email investorrelations@kayaindia.net

Website www.kaya.in

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

27Dec Kaya informs about press release
In terms of the Securities and Exchange Board of India (Listing Obligati..
21Dec Kaya informs about outcome of board me
Kaya has informed that the Board of Directors of the Company have approv..
15Nov Kaya’s arm sells entire stake in MMC,
Kaya’s material subsidiary -- Kaya Middle East DMCC (DMCC) has sold its..
03Nov Kaya informs about disclosure
Kaya has informed the stock exchanges that in continuation to the disclo..
20Oct Kaya informs about board meeting
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosur..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit-28.7999999999999-854.85
Gross Profit -28.7999999999999 -854.85
Operating Profit 127.69-237.76
Net Sales 556.341783.11

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Apollo Hospital Ent. (BSE)
peergroup  6170.05 (1.68%)
M.Cap ( in Cr)88715.85
Global Health (BSE)
peergroup  1402.45 (2.25%)
M.Cap ( in Cr)37656.82
Dr Agarwals Eye Hsp (BSE)
peergroup  3282.00 (0.94%)
M.Cap ( in Cr)1542.54
Thyrocare Tech. (BSE)
peergroup  634.85 (2.99%)
M.Cap ( in Cr)3361.70
Yatharth Hospital (BSE)
peergroup  460.10 (2.39%)
M.Cap ( in Cr)3949.97

Shareholding Pattern

PROMOTERS 59.79%
NON-INSTITUTION 37.49%
FI/BANKS/INSURANCE 0%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Kaya Ltd.

Kaya Ltd. was incorporated in the year 2003. Its today's share price is 339.85. Its current market capitalisation stands at Rs 443.98 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1783.11 Cr and Total Income of Rs.1821.66 Cr. The company's management includes Nitika Dalmia, Vasuta Agarwal, Om Manchanda, Irfan Mustafa, BS Nagesh, Nikhil Khattau, Rishabh Mariwala, Rajendra Mariwala, Harsh Mariwala, Harsh Mariwala.

It is listed on the BSE with a BSE Code of 539276 , NSE with an NSE Symbol of KAYA and ISIN of INE587G01015. It's Registered office is at Marks, 23/ C, Mahal Industrial Estate, Mahakali Caves Road,Near Paperbox Lane,Andheri (East)Mumbai-400093, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co LLP, Price Waterhouse

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.